In experimental NEC, targeted inhibition or conditional deletion of TLR4 in ISCs preserves stem cell function, speeds up epithelial recovery, and significantly decreases disease severity [20,112,113]. The gene discussed is TLR4; the disease is necrotizing enterocolitis.